市場調査レポート

商品コード

1619107

コネクテッドドラッグデリバリーデバイス市場規模、シェア、成長分析、製品タイプ別、技術別、用途別、エンドユーザー別、地域別 - 産業予測、2024～2031年

Connected Drug Delivery Devices Market Size, Share, Growth Analysis, By Product Type (Connected Inhalers, Metered Dose Inhalers (MDIs)), By Technology (Bluetooth, Wi-Fi), By Application, By End-User, By Region - Industry Forecast 2024-2031

出版日: 2024年12月17日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 763,518円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 893,172円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,022,826円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=144.06円

全表示
概要
目次

概要

サンプル依頼リストに入れる

コネクテッドドラッグデリバリーデバイスの世界市場規模は、2022年に3億4,790万米ドルと評価され、2023年の4億3,348万米ドルから2031年には25億1,835万米ドルに成長し、予測期間中（2024年～2031年）のCAGRは24.6％で成長する見通しです。

世界のコネクテッドドラッグデリバリーデバイス市場は、デジタルヘルスソリューションの普及と個別化ヘルスケアの需要の高まりに後押しされ、大きな成長を遂げようとしています。これらの革新的なデバイスは、患者と介護者にリアルタイムのデータ追跡、リマインダー、通知を提供し、投薬管理と患者の転帰を改善します。IoT、AI、クラウドコンピューティングのような先進技術はドラッグデリバリーシステムを変革し、患者エンゲージメントの強化を促進し、遠隔モニタリングを容易にしています。ヘルスケアシステムがデジタルトランスフォーメーションと患者中心のアプローチを優先させる中、市場は大幅に拡大するとみられ、より良い患者体験と転帰のために技術統合をますます受け入れるようになるヘルスケア提供の移り変わりを反映しています。

市場概要
コネクテッド吸入器
- 定量噴霧式吸入器（MDI）
- ドライパウダー吸入器（DPI）
コネクテッド注射装置
- コネクテッド自動注射器
- コネクテッドペン型注射器
- コネクテッドウェアラブルインジェクター
コネクテッド監視デバイス
- スマートピル
- スマートパッチ

コネクテッドドラッグデリバリーデバイス市場規模：技術別およびCAGR（2024～2031年）

市場概要
Bluetooth
Wi-Fi
近距離無線通信（NFC）
その他

コネクテッドドラッグデリバリーデバイス市場規模：用途別およびCAGR（2024～2031年）

市場概要
糖尿病
- インスリン投与
喘息とCOPD
- 気管支拡張薬の投与
心血管疾患
- 抗凝固剤の投与
その他
- ホルモン補充療法
- 疼痛管理

コネクテッドドラッグデリバリーデバイス市場規模：エンドユーザー別およびCAGR（2024～2031年）

市場概要
病院
- 大規模病院
- 中小規模の病院
ホームケア設定
- 個々の患者
- 介護者
クリニック
- 専門クリニック
- 一般診療所

コネクテッドドラッグデリバリーデバイス市場規模およびCAGR（2024～2031年）

北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- イタリア
- その他欧州地域
アジア太平洋地域
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋地域
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東・アフリカ
- GCC諸国
- 南アフリカ
- その他中東・アフリカ

競合情報

上位5社の比較
主要企業の市場ポジショニング（2023年）
主な市場企業が採用した戦略
市場の最近の動向
企業の市場シェア分析（2023年）
主要企業の企業プロファイル
- 会社概要
- 製品ポートフォリオ分析
- セグメント別シェア分析
- 収益の前年比比較（2021～2023年）

主要企業プロファイル

Findair Sp. z o. o.（Poland）
BIO CORP（France）
Teva Pharmaceuticals Industries Ltd（Israel）
Adherium Limited（New Zealand）
West Pharmaceutical Services Inc.（USA）
Aptar Pharma（USA）
Ypsomed AG（Switzerland）
Phillips-Medisize（USA）
H&T Presspart Manufacturing Ltd（UK）
Cohero Health, Inc.（USA）
3M Company（USA）
Becton, Dickinson and Company（USA）
Merck KGaA（Germany）
Novartis AG（Switzerland）
Johnson & Johnson（USA）
AstraZeneca（UK）
GlaxoSmithKline plc（UK）
Pfizer Inc.（USA）
Sanofi S.A.（France）
F. Hoffmann-La Roche Ltd（Switzerland）

結論と推奨事項

Product Code: SQMIG35G2246

Global Connected Drug Delivery Devices Market size was valued at USD 347.9 million in 2022 and is poised to grow from USD 433.48 million in 2023 to USD 2518.35 million by 2031, growing at a CAGR of 24.6% during the forecast period (2024-2031).

The global connected drug delivery devices market is poised for significant growth, fueled by the rising adoption of digital health solutions and the demand for personalized healthcare. These innovative devices provide real-time data tracking, reminders, and notifications for patients and caregivers, improving medication management and patient outcomes. Advanced technologies like IoT, AI, and cloud computing are transforming drug delivery systems, fostering enhanced patient engagement and facilitating remote monitoring. As healthcare systems prioritize digital transformation and patient-centric approaches, the market is set to expand substantially, reflecting a shifting landscape in healthcare delivery that increasingly embraces technological integration for better patient experiences and outcomes.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Connected Drug Delivery Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Connected Drug Delivery Devices Market Segmental Analysis

Global Connected Drug Delivery Devices Market is segmented by product type, technology, application, end-user and region. Based on product type, the market is segmented into connected inhalers, connected injection devices and connected monitoring devices. Based on technology, the market is segmented into bluetooth, wi-fi, near field communication (NFC) and others. Based on application, the market is segmented into diabetes, asthma & COPD, cardiovascular diseases and other. Based on end-user, the market is segmented into hospitals, homecare settings and clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Connected Drug Delivery Devices Market

A significant driver for the global connected drug delivery devices market is the rising demand for personalized and interconnected healthcare solutions. These innovative devices provide numerous advantages, including remote patient tracking, real-time data collection, and enhanced medication adherence. By allowing healthcare professionals to monitor patient health continuously, they can adjust treatment plans accordingly and deliver tailored care. Furthermore, the incorporation of connected technologies into drug delivery systems fosters greater patient engagement and leads to improved treatment outcomes. The escalating incidence of chronic diseases and the increasing need for sophisticated drug delivery mechanisms also play essential roles in propelling the growth of this market.

Restraints in the Global Connected Drug Delivery Devices Market

A major constraint facing the global connected drug delivery devices market is the substantial cost linked to these advanced technologies. These devices incorporate intricate components such as wireless connectivity and sophisticated data management systems, which collectively contribute to elevated pricing. Such financial implications can hinder widespread acceptance, especially in low-resource environments and developing countries, where budgetary limitations are critical. This cost-related barrier restricts the availability and use of connected drug delivery devices among various patient demographics and healthcare frameworks. To facilitate broader market growth and enhance adoption rates, it is crucial to tackle affordability issues effectively.

Market Trends of the Global Connected Drug Delivery Devices Market

The global connected drug delivery devices market is witnessing a significant trend towards the adoption of smart inhalers and connected devices, especially for respiratory therapies. These advanced devices leverage sensors, wireless connectivity, and mobile applications to facilitate comprehensive tracking of medication usage, dosage accuracy, and patient adherence. The incorporation of digital technologies not only enables real-time data collection and remote monitoring but also supports personalized treatment plans tailored to individual patient needs. This trend fosters enhanced patient engagement and empowerment, as users gain valuable insights and feedback on their medication habits, ultimately driving improved health outcomes and ensuring greater adherence to treatment protocols.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2023
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Technological Advancement
Regulatory Landscape
Patent Analysis
Case Studies
Startup Analysis

Global Connected Drug Delivery Devices Market Size by Product Type & CAGR (2024-2031)

Market Overview
Connected Inhalers
- Metered Dose Inhalers (MDIs)
- Dry Powder Inhalers (DPIs)
Connected Injection Devices
- Connected Auto-Injectors
- Connected Pen Injectors
- Connected Wearable Injectors
Connected Monitoring Devices
- Smart Pills
- Smart Patches

Global Connected Drug Delivery Devices Market Size by Technology & CAGR (2024-2031)

Market Overview
Bluetooth
Wi-Fi
Near Field Communication (NFC)
Others

Global Connected Drug Delivery Devices Market Size by Application & CAGR (2024-2031)

Market Overview
Diabetes
- Insulin Delivery
Asthma & COPD
- Bronchodilator Delivery
Cardiovascular Diseases
- Anticoagulant Delivery
Other
- Hormone Replacement Therapy
- Pain Management

Global Connected Drug Delivery Devices Market Size by End-User & CAGR (2024-2031)

Market Overview
Hospitals
- Large Hospitals
- Small and Medium-Sized Hospitals
Homecare Settings
- Individual Patients
- Caregivers
Clinics
- Specialty Clinics
- General Clinics

Global Connected Drug Delivery Devices Market Size & CAGR (2024-2031)

North America (Product Type, Technology, Application, End-User)
- USA
- Canada
Europe (Product Type, Technology, Application, End-User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product Type, Technology, Application, End-User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product Type, Technology, Application, End-User)
- Brazil
- Rest of Latin America
Middle East & Africa (Product Type, Technology, Application, End-User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2023
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

Findair Sp. z o. o. (Poland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BIO CORP (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Teva Pharmaceuticals Industries Ltd (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Adherium Limited (New Zealand)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
West Pharmaceutical Services Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Aptar Pharma (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ypsomed AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Phillips-Medisize (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
H&T Presspart Manufacturing Ltd (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cohero Health, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
3M Company (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novartis AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AstraZeneca (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GlaxoSmithKline plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pfizer Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sanofi S.A. (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche Ltd (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments